PDD Holdings Best Performer in the Nasdaq 100 SO Far Today — Data Talk
PDD Holdings Inc. Sponsored ADR Class A (PDD) is currently at $108.01, up $5.71 or 5.58%
--Would be highest close since Aug. 23, 2024, when it closed at $139.87
--On pace for largest percent increase since May 2, 2024, when it rose 10.48%
--Currently up three of the past four days
--Currently up two consecutive days; up 8.12% over this period
--Best two day stretch since the two days ending May 3, 2024, when it rose 12.6%
--Up 12.38% month-to-date; on pace for best month since May 2024, when it rose 19.65%
--Down 26.18% year-to-date
--Down 46.75% from its all-time closing high of $202.82 on Feb. 17, 2021
--Up 14.99% from 52 weeks ago (Sept. 26, 2023), when it closed at $93.93
--Down 31.45% from its 52-week closing high of $157.57 on May 24, 2024
--Up 21.13% from its 52-week closing low of $89.17 on Aug. 28, 2024
--Traded as high as $110.01; highest intraday level since Aug. 26, 2024, when it hit $111.67
--Up 7.54% at today's intraday high; largest intraday percent increase since May 23, 2024, when it rose as much as 8.78%
--Best performer in the Nasdaq 100 today
--Fourth most active stock in the Nasdaq 100 today
All data as of 10:05:37 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 24, 2024 10:24 ET (14:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk